Silver Spike Investment (Silver Spike Investment) Debt-to-Equity : 0.00 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Silver Spike Investment Debt-to-Equity?

Silver Spike Investment's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.00 Mil. Silver Spike Investment's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.00 Mil. Silver Spike Investment's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $84.52 Mil. Silver Spike Investment's debt to equity for the quarter that ended in Mar. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Silver Spike Investment's Debt-to-Equity or its related term are showing as below:

SSIC's Debt-to-Equity is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.29
* Ranked among companies with meaningful Debt-to-Equity only.

Silver Spike Investment Debt-to-Equity Historical Data

The historical data trend for Silver Spike Investment's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Silver Spike Investment Debt-to-Equity Chart

Silver Spike Investment Annual Data

Trend

Mar21

Mar22

Dec23

Debt-to-Equity

Silver Spike Investment Quarterly Data
	Jun21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of Silver Spike Investment's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Silver Spike Investment's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Silver Spike Investment's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Silver Spike Investment's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Silver Spike Investment's Debt-to-Equity falls into.

Silver Spike Investment Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Silver Spike Investment's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	85.553
	=	0.00

Silver Spike Investment's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	84.519
	=	0.00

Silver Spike Investment (NAS:SSIC) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Silver Spike Investment Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Silver Spike Investment's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Silver Spike Investment (Silver Spike Investment) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Silver Spike Investment Corp (NAS:SSIC) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

600 Madison Avenue, Suite 1800, New York, NY, USA, 10022

Website

https://www.silverspikecap.com

Silver Spike Investment Corp is a closed-end management investment company formed to invest in companies across the cannabis ecosystem through investments in the form of direct loans to, and equity ownership of, privately-held cannabis businesses.

Executives

Umesh Mahajan	officer: Chief Financial Officer	600 MADISON AVENUE, SUITE 1800, NEW YORK NY 10022
Scott Gordon	director, 10 percent owner, officer: Chief Executive Officer	1114 6TH AVE, 41ST FLOOR, NEW YORK NY 10036
Gregory M. Gentile	10 percent owner, officer: CFO, CCO & Sec.	1114 6TH AVE, 41ST FLOOR, NEW YORK NY 10036
Silver Spike Capital, Llc	10 percent owner	600 MADISON AVE, SUITE 1800, NEW YORK NY 10022
Warson Tracey Brophy	director	1350 AVENUE OF THE AMERICAS, NEW YORK NY 10019
Silver Spike Holdings, Lp	10 percent owner	600 MADISON AVENUE, SUITE 1800, NEW YORK NY 10022
Michael William Chorske	director	660 MADISON AVENUE, SUITE 1600, NEW YORK NY 10065
Vivek Bunty Bohra	director	660 MADISON AVENUE, SUITE 1600, NEW YORK NY 10065
Silver Spike Holdings Gp, Llc	10 percent owner	660 MADISON AVENUE, SUITE 1600, NEW YORK NY 10065
Da Corte Americo	director	660 MADISON AVENUE, SUITE 1600, NEW YORK NY 10065